Justin talks about diseases of poverty, developing new therapeutics and treatments for Parkinson’s disease.
Visit the Chemistry World article here http://www.rsc.org/chemistryworld/Issues/2010/July/HealthBreakThroughsDecade.asp
LifeArc’s Chief Scientific Officer Dr Dave Powell comments on news that lecanemab has received regulatory and safety approval from the FDA.
We’ve seen some exciting scientific progress, forged new partnerships and launched some new landmark initiatives.
We cautiously welcome the Government's announcement on how their £50m commitment into MND research will be spent.